The Research Center for Amyotrophic Lateral Sclerosis (ALS Center) brings together the groups that are involved in ALS research from an epidemiological, preclinicaland translational point of view.
The centre is involved in health economics and health policy research. The main areas of research are: Economic Evaluation of Health Care Programs and Comparative Health Policy Analysis.
The Centre promotes and facilitates interdisciplinary research for health and the environment, using mass spectrometry technologies.
The Center promotes independent clinical research and evaluates and discusses clinical research methodology, pharmaceutical legislation and health policies, to highlight their limitations and propose useful solutions to the public.
The register of clinical trials was created in 2011. The main aims of the register are:
- to ensure transparent and accessible information on clinical research conducted by the Institute
- to promote trial registration and research collaboration among researchers
The Registry collects clinical data and biological samples of subjects with membranoproliferative glomerulonephritis (MPGN) and C3 glomerulopathy (C3G), and of their family members, in order to study biochemical and genetic abnormalities and improve the possibility of treatment.
The Registry collects clinical data and biological samples of subjects with atypical haemolytic uremic syndrome (aHUS) and thrombotic thrombocytopenic purpura (PTT), and of their family members, with the aim of studying biochemical and genetic abnormalities and improving the possibility of treatment.
Registry collects clinical data and biological samples of subjects with Steroid-Resistant Nephrotic Syndrome (SRNS), and of their family members, with the aim of studying genetic abnormalities and improving the possibility of treatment.
The Registry collects, in an organized multicenter structure, the data of all patients from Lombardy who were diagnosed with ALS from 1998 to 2002.
Over the years the Mario Negri Institute has created a vast network of collaborations, involving clinical centers, general medical associations, hospitals and universities. This led to important research projects.
read moreThe Animal Care Unit ensures that all experiments carried out on laboratory animals are conducted t in compliance with current legislation and according to widely shared international criteria.
read moreEstablished in 2014 by the Departments of Oncology and Cardiovascular Research, the Mario Negri Institute Biological Resources Center (BRC) collects and stores biological samples and related data for the purposes of biomedical research.
read moreThe Quality Assurance and Regulatory Affairs for Clinical Studies Activity ensures that all clinical studies are conducted according to current regulations.
read moreThe impact factor (Impact Factor or IF) measures the frequency with which a scientific article is taken over in a given year by other journals. It is the most common method for empirically assessing the importance and credibility of these journals.
Loading...
International Consensus on Cardiopulmonary Resuscitation.
A comparison of metrics and performance characteristics of different search strategies.
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells
ADAMTS13 deficiency shortens the lifespan of mice with experimental diabetes.
ADHD prevalence estimates in Italian children and adolescents: a methodological issue.
A disease looking for innovative drugs: The case of pulmonary arterial hypertension.
Intercheck web: web application aimed at health professionals to support the proper prescription of drugs in the elderly.
Information service for pregnant and nursing mothers on the appropriate use of medicines.
Information service for health professionals and patients on treatment plans and rare diseases.
Information service for health professionals and patients on kidney diseases and transplants.
Information services aimed at health professionals and the general public on the correct use of drugs, side effects and interactions in the elderly.
